🚨 IMPORTANT: Even if the FDA moves certain peptides to the compounding list, they remain prescription-only.
You need documented medical justification.
That’s why $hims launched Labs.
These are Hims-tested biomarkers → and potential prescription peptide treatments if legally allowed:
Elevated HbA1c (Hims Labs) →
Low IGF-1 (Hims Labs) → CJC-1295 + Ipamorelin
High CRP / inflammation (Hims Labs) → BPC-157 or TB-500
High cortisol / sleep markers (Hims Labs) → DSIP or Selank
Hey Nurse, I’ve always respected your analysis and posts about $HIMS — whether they were positive or negative. You’ve raised many valid criticisms in the past.
But lately it feels less like analysis and more like defending your position against Hims no matter what.
The strongest move wouldn’t be countering every criticism of your views, but simply acknowledging that maybe you sold too early and continuing to analyze the company objectively — good news or bad
🚨BREAKING
: With the new $HIMS–Novo Nordisk partnership, not only is the lawsuit issue gone —
more importantly, Hims will likely be one of the few telehealth providers able to offer the oral Wegovy pill.
🚨BREAKING:
MyJuniper Germany ($HIMS) lists a Novo Nordisk GLP-1 weight-loss injection for 172€ (~$188)
ZAVA Germany, also owned by $HIMS, offers it for 200€ (~$219)